| MolName | N-(oxolan-2-ylmethyl)-2-[3-[(E)-[2,4,6-trioxo-1-(thiophen-2-ylmethyl)-1,3-diazinan-5-ylidene]methyl]indol-1-yl]acetamide |
| MolecularFormula | C25H24N4O5S |
| Smiles | O=C(Cn1c(cccc2)c2c(/C=C(\C(NC(N2Cc3cccs3)=O)=O)/C2=O)c1)NCC1OCCC1 |
| InChI | InChI=1S/C25H24N4O5S/c30-22(26-12-17-5-3-9-34-17)15-28-13-16(19-7-1-2-8-21(19)28)11-20-23(31)27-25(33)29(24(20)32)14-18-6-4-10-35-18/h1-2,4,6-8,10-11,13,17H,3,5,9,12,14-15H2,(H,26,30)(H,27,31,33)/t17-/m1/s1 |
| InChIK | UWHVLFZQCZKZOT-QGZVFWFLSA-N |
| TotalMolweight | 492.555 |
| Molweight | 492.555 |
| MonoisotopicMass | 492.146741 |
| CLogP | 1.3503 |
| CLogS | -3.72 |
| H Acceptors | 9 |
| H Donors | 2 |
| TotalSurfaceArea | 359.75 |
| Relative PSA | 0.32206 |
| PolarSurfaceArea | 137.98 |
| Druglikeness | 6.1521 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.51429 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 10 |
| Electronegative Atoms | 10 |
| StereoCenters | 1 |
| Rotatable Bond | 7 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 14 |
| Sp3Atoms | 8 |
| Amides | 3 |
| Aromatic Nitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - N-(oxolan-2-ylmethyl)-2-[3-[(E)-[2,4,6-trioxo-1-(thiophen-2-ylmethyl)-1,3-diazinan-5-ylidene]methyl]indol-1-yl]acetamide | 2 - N-(oxolan-2-ylmethyl)-2-[3-[(E)-[2,4,6-trioxo-1-(thiophen-2-ylmethyl)-1,3-diazinan-5-ylidene]methyl]indol-1-yl]acetamide